Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens A Cohort Study Using National Registry Data



Frost, Freddy J ORCID: 0000-0002-3902-6502, Nazareth, Dilip S ORCID: 0000-0002-6114-0467, Charman, Susan C, Winstanley, Craig ORCID: 0000-0002-2662-8053 and Walshaw, Martin J
(2019) Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens A Cohort Study Using National Registry Data. ANNALS OF THE AMERICAN THORACIC SOCIETY, 16 (11). 1375 - 1382.

[img] Text
IVA_Manuscript_2.3_R1-ACCEPTED.pdf - Accepted Version

Download (260kB) | Preview
Item Type: Article
Uncontrolled Keywords: cystic fibrosis, ivacaftor, Pseudomonas aeruginosa
Depositing User: Symplectic Admin
Date Deposited: 09 Jan 2020 08:43
Last Modified: 30 Dec 2021 09:10
DOI: 10.1513/AnnalsATS.201902-122OC
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3069887